本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Dermata Therapeutics Inc

1.15
-0.0400-3.36%
盤後1.160.0100+0.87%19:55 EDT
成交量:1.78萬
成交額:2.11萬
市值:462.55萬
市盈率:-0.26
高:1.27
開:1.18
低:1.15
收:1.19
52周最高:6.22
52周最低:0.9509
股本:402.21萬
流通股本:302.29萬
量比:0.58
換手率:0.59%
股息:- -
股息率:- -
每股收益(TTM):-4.3864
每股收益(LYR):-8.1609
淨資產收益率:-183.89%
總資產收益率:-89.88%
市淨率:1.33
市盈率(LYR):-0.14

資料載入中...

2022/05/05

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/05/04

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2022/04/25

重要事件披露

8-K - Current report
2022/03/28

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/28

重要事件披露

8-K - Current report
2022/03/02

重要事件披露

8-K - Current report
2022/02/07

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/02/04

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2022/02/04

重要事件披露

8-K - Current report
2022/02/04

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2022/01/13

重要事件披露

8-K - Current report
2021/12/10

重要事件披露

8-K - Current report
2021/12/10

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/11/26

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/01

重要事件披露

Dermata Therapeutics, Inc.
2021/09/01

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/09/01

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/08/27

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/08/27

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/08/10

SEC問詢函

CORRESP [Cover] - Correspondence